Home List your patent My account Help Support us

Smart Contact Lens for Blood-Free Health Monitoring Patent Pending

[Category : - HEALTH]
[Viewed 408 times]

This invention is a next-generation smart contact lens that continuously tracks critical health biomarkers through tear fluid, eliminating the need for invasive blood testing.

The lens integrates:

Nano-biosensors that detect glucose, lactate, electrolytes, and early inflammation markers.

Micro-wireless circuitry that transmits readings in real time to smartphones or medical dashboards.

Adaptive optics so the lens remains transparent and comfortable while functioning as a medical device.

It solves the global problem of painful, delayed, or costly blood-based diagnostics by making testing continuous, painless, and invisible.

Benefits over existing technologies:

Non-invasive ? Replaces finger-pricks and frequent lab draws.

Continuous monitoring ? Provides real-time data instead of occasional snapshots.

Early-warning system ? Detects disease progression (e.g., diabetes, dehydration, sepsis, infections) before symptoms arise.

Lifestyle integration ? Doubles as a normal contact lens, comfortable for daily wear.

This invention turns eye-wear into a life-saving diagnostic platform, accessible to millions worldwide.

Financial information

Diabetes care alone costs $966 billion annually worldwide; continuous glucose monitoring is one of the fastest-growing markets.

The global smart contact lens market is projected to exceed $20 billion by 2032, with huge interest from pharma, med-tech, and consumer health companies.

Chronic disease management (diabetes, heart disease, kidney disease) represents a multi-trillion-dollar burden that insurers and governments are desperate to reduce.

Revenue pathways:

Medical device sales via hospitals, clinics, and insurers.

Subscription models for patients requiring continuous monitoring.

Licensing deals with pharmaceutical companies and device makers.

Data-as-a-service ? Longitudinal biomarker data for research and drug development.

By merging ophthalmic devices and biosensing, this invention creates a new category of diagnostics — invisible, always-on, and accessible.

Patent publications:

No publication

Asking price:

100,000 USD

Rate this patent

Great invention
Viewed: 408 times

Seller:

chels99 (United Kingdom)

Ask a question
or start a negotiation

Contact the seller

Share on social media